Related Experiment Videos
QS-21 structure/function studies: effect of acylation on adjuvant activity
Gui Liu1, Christine Anderson, Heidi Scaltreto
1Antigenics Inc., 175 Crossing Boulevard, Framingham, MA 01702-4473, USA. gliu@antigenics.com
Vaccine
|May 30, 2002
Summary
QS-21 saponin adjuvant acylation is key for immune response. Deacylated (DS-1) and modified (RDS-1) forms showed varied IgG1, IgG2a, and CTL responses in mice, highlighting structural importance.
Area of Science:
- Immunology
- Natural Products Chemistry
Background:
- QS-21, a saponin adjuvant from *Quillaja saponaria* Molina, is crucial for vaccine efficacy.
- Previous research indicated acylation is vital for QS-21's adjuvant activity within a narrow dose range.
Purpose of the Study:
- To investigate the dose-response effects of deacylated QS-21 (DS-1) and a modified version (RDS-1) on immune responses in mice.
- To determine the impact of acylation site and extent on adjuvant function over a broader dose range.
Main Methods:
- Preparation of DS-1 (deacylated QS-21) and RDS-1 (reacylated DS-1).
- Administration of QS-21, DS-1, and RDS-1 to mice across a wide dose range.
- Quantification of IgG1, IgG2a antibody responses and cytotoxic T lymphocyte (CTL) activity.
Main Results:
- Both DS-1 and RDS-1 elicited IgG1 responses at higher doses than QS-21.
- DS-1 demonstrated no IgG2a or CTL activity at any tested dose.
- RDS-1 induced a moderate IgG2a response at 240 µg but no CTL activity.
Conclusions:
- Acylation significantly influences the dose-dependent immune response profile of QS-21.
- The specific acylation pattern and site affect the induction of different immune mediators (IgG1, IgG2a, CTL).
- Structural modifications of QS-21 can alter its adjuvant properties, impacting potential vaccine development.